LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 59.85 | 27.76 | 3138 | 6062 | 0.5176 | 0.8375 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 59.85 | 27.76 | 3253 | 6062 | 0.5366 | 0.8460 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.56 | 27.76 | 3068 | 6217 | 0.4935 | 0.8270 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.56 | 27.76 | 3141 | 6217 | 0.5052 | 0.8325 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.56 | 27.76 | 3229 | 6217 | 0.5194 | 0.8390 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.56 | 27.76 | 3345 | 6217 | 0.5380 | 0.8474 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.26 | 27.76 | 3214 | 6465 | 0.4971 | 0.8299 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.26 | 27.76 | 3305 | 6465 | 0.5112 | 0.8364 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.26 | 27.76 | 3301 | 6465 | 0.5105 | 0.8361 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.26 | 27.76 | 3438 | 6465 | 0.5317 | 0.8456 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.97 | 27.76 | 3329 | 6656 | 0.5001 | 0.8322 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.97 | 27.76 | 3437 | 6656 | 0.5163 | 0.8396 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.97 | 27.76 | 3330 | 6656 | 0.5002 | 0.8322 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.97 | 27.76 | 3556 | 6656 | 0.5342 | 0.8475 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 66.67 | 27.76 | 3458 | 6695 | 0.5165 | 0.8398 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 66.67 | 27.76 | 3572 | 6695 | 0.5335 | 0.8474 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 66.67 | 27.76 | 3323 | 6695 | 0.4963 | 0.8306 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 66.67 | 27.76 | 3603 | 6695 | 0.5381 | 0.8494 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 68.37 | 27.76 | 3559 | 6879 | 0.5174 | 0.8410 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 68.37 | 27.76 | 3691 | 6879 | 0.5365 | 0.8494 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 68.37 | 27.76 | 3260 | 6879 | 0.4739 | 0.8208 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 68.37 | 27.76 | 3742 | 6879 | 0.5440 | 0.8526 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.08 | 27.76 | 3725 | 6849 | 0.5438 | 0.8524 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.08 | 27.76 | 3857 | 6849 | 0.5631 | 0.8606 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.08 | 27.76 | 2418 | 6849 | 0.3530 | 0.7544 | MN20160318_Q01 | M06 |